DELRAY BEACH, FL / ACCESS Newswire / February 4, 2025 / Adolore BioTherapeutics ("Adolore" or the "Company"), is developing intracellularly-delivered neuromodulators that naturally reduce neuronal exc ...

announced the publication of a study in Pain Management journal showing that the use of Nalu PNS therapy in chronic pain patients is associated with lower healthcare resource utilization (HCRU ...

SPR announces four featured abstracts that will be presented at the upcoming North American Neuromodulation Society (NANS) ...

Several factors influence the frequency and severity of chronic peripheral neuropathic pain, including type and dose of chemotherapy, pre-existing neuropathy, and the use of other drugs that can ...

Introduction Genicular artery embolisation (GAE) is an innovative procedure in interventional radiology that has emerged as ...

Chronic pain – symptom or disease? Chronic pain affects 10-20% of the general ... The neuroimmune cross-talk between peripheral tissues and brain in patients suffering from knee osteoarthritis, ...